Brief: Nanobiotix SA Says €39.8 Million In Cash And Cash Equivalents As Of March 31, 2025
21/05/2025 21:19
May 21 (Reuters) - Nanobiotix SA NANOB.PA: NANOBIOTIX SA - €39.8 MILLION IN CASH AND CASH EQUIVALENTS AS OF MARCH 31, 2025 Source text: ID:nGNE5K4Srh Further company coverage: NANOB.PA ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nanobiotix SA
See all newsBrief: Nanobiotix S.A. H1 Net Income EUR -34.3 Million
France's Nanobiotix H1 net loss widens on lower revenue, absence of 2025 one-off gain
Brief: Nanobiotix Reports Encouraging Full Phase 1 Results For Lung Cancer Drug JNJ-1900
Brief: Nanobiotix Q1 Cash And Cash Equivalents Of €42.1 Mln
Brief: NANOBIOTIX Announces Closing Of Global Offering